Nasdaq-listed Sonnet shareholders greenlight merger, creating potential $1B HYPE digital-asset treasury after extended delay
Summary — Shareholders of Nasdaq-listed Sonnet BioTherapeutics Holdings, Inc. (SONN) approved a business combination on Dec. 2 that converts the small-cap









